ARRIVENT BIOPHARMA INC

Ticker: AVBP CUSIP: 04272N102 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 73,111 Value ($000) $1,471 Avg Close $20.82 Range $17.00 - $25.82

Q3 2025

Shares 63,283 Value ($000) $1,168 Avg Close $19.65 Range $16.10 - $23.38

Q2 2025

Shares 58,778 Value ($000) $1,280 Avg Close $20.76 Range $15.47 - $25.80

Q1 2025

Shares 68,225 Value ($000) $1,261 Avg Close $24.47 Range $17.84 - $29.71

Q4 2024

Shares 68,003 Value ($000) $1,812 Avg Close $28.71 Range $23.00 - $36.37

Q3 2024

Shares 68,321 Value ($000) $1,606 Avg Close $22.70 Range $17.21 - $30.99

Q2 2024

Shares 29,847 Value ($000) $554 Avg Close $17.83 Range $14.35 - $21.00

Q1 2024

Shares 22,707 Value ($000) $406 Avg Close $20.17 Range $16.90 - $25.95

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	73,111	$1,471	$20.82	$17.00 - $25.82
Q3 2025	63,283	$1,168	$19.65	$16.10 - $23.38
Q2 2025	58,778	$1,280	$20.76	$15.47 - $25.80
Q1 2025	68,225	$1,261	$24.47	$17.84 - $29.71
Q4 2024	68,003	$1,812	$28.71	$23.00 - $36.37
Q3 2024	68,321	$1,606	$22.70	$17.21 - $30.99
Q2 2024	29,847	$554	$17.83	$14.35 - $21.00
Q1 2024	22,707	$406	$20.17	$16.90 - $25.95